Psychopharmacological Effects of Alkaloid Z77 under Conditions of Posthypoxic Encephalopathy and Mechanisms of Their Development


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Psychopharmacological effects of atisine-type diterpene alkaloid Z77 were studied under conditions of experimental posthypoxic encephalopathy. The preparation had a pronounced cerebroprotective effect consisting in normalization of orientation and exploratory behavior and conditioned activity in experimental animals. These changes were accompanied by significant increase in the number of neural stem cells in the paraventricular region of the brain and markedly enhanced production of neurotrophic growth factors by neural tissue microenvironment cells.

Sobre autores

G. Zyuz’kov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; Tomsk National Research State University

Autor responsável pela correspondência
Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

E. Losev

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

A. Chaikovskii

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

N. Suslov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

L. Miroshnichenko

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Simanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

T. Polyakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

T. Povet’eva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

Yu. Nesterova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

L. Stavrova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

V. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; Tomsk National Research State University

Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

M. Minakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

A. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies